Literature DB >> 20546957

Technologies for MHC class I immunoproteomics.

Rieuwert Hoppes1, Reggy Ekkebus, Ton N M Schumacher, Huib Ovaa.   

Abstract

T cell epitopes are peptides, for instance derived from foreign, mutated or overexpressed proteins, that are displayed by MHC molecules on the cell surface and that are recognized by T lymphocytes. Knowledge of the identity of epitopes displayed by MHC molecules is of high value for diagnostic purposes and for the development of prophylactic and therapeutic immunotherapy regimens. Here we review key techniques in MHC class I epitope definition and we discuss recent developments in epitope discovery and their implications. Developments in epitope discovery strategies should ultimately lead to the definition of the MHC-associated peptidome.
Copyright © 2010 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2010        PMID: 20546957     DOI: 10.1016/j.jprot.2010.05.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  8 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  The Human Immunopeptidome Project, a suggestion for yet another postgenome next big thing.

Authors:  Arie Admon; Michal Bassani-Sternberg
Journal:  Mol Cell Proteomics       Date:  2011-08-02       Impact factor: 5.911

3.  The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.

Authors:  Elena Milner; Lilach Gutter-Kapon; Michal Bassani-Strenberg; Eilon Barnea; Ilan Beer; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2013-03-28       Impact factor: 5.911

4.  Quantitative shotgun proteomics: considerations for a high-quality workflow in immunology.

Authors:  Felix Meissner; Matthias Mann
Journal:  Nat Immunol       Date:  2014-02       Impact factor: 25.606

Review 5.  T-cell receptor gene therapy--ready to go viral?

Authors:  Terhi Karpanen; Johanna Olweus
Journal:  Mol Oncol       Date:  2015-10-20       Impact factor: 6.603

Review 6.  Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool.

Authors:  Christopher L Karp; Christopher B Wilson; Lynda M Stuart
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 7.  Therapeutic Antibodies against Intracellular Tumor Antigens.

Authors:  Iva Trenevska; Demin Li; Alison H Banham
Journal:  Front Immunol       Date:  2017-08-18       Impact factor: 7.561

8.  Identification of HLA-A*11:01-restricted Mycobacterium tuberculosis CD8(+) T cell epitopes.

Authors:  Su-Dong Liu; Jin Su; Shi-Meng Zhang; Hai-Ping Dong; Hui Wang; Wei Luo; Qian Wen; Jian-Chun He; Xiao-Fan Yang; Li Ma
Journal:  J Cell Mol Med       Date:  2016-04-12       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.